The new law prioritizes patient health and patient access, protecting Texans’ ability to receive pharmacy services from their chosen pharmacy provider.
Sun Pharma will be able to manufacture and sell a limited quantity of generic lenalidomide capsules after March 2022, as well as an unlimited quantity beginning Jan. 31, 2026.